Franz Hartmann

6.2k total citations · 1 hit paper
93 papers, 4.1k citations indexed

About

Franz Hartmann is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Epidemiology. According to data from OpenAlex, Franz Hartmann has authored 93 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Cardiology and Cardiovascular Medicine, 34 papers in Surgery and 15 papers in Epidemiology. Recurrent topics in Franz Hartmann's work include Acute Myocardial Infarction Research (23 papers), Cardiac Imaging and Diagnostics (14 papers) and Coronary Interventions and Diagnostics (14 papers). Franz Hartmann is often cited by papers focused on Acute Myocardial Infarction Research (23 papers), Cardiac Imaging and Diagnostics (14 papers) and Coronary Interventions and Diagnostics (14 papers). Franz Hartmann collaborates with scholars based in Germany, United States and Poland. Franz Hartmann's co-authors include Giulio Guagliumi, Roxana Mehran, Gregg W. Stone, Ran Kornowski, Bernhard Witzenbichler, Dariusz Dudek, Jan Z. Peruga, George Dangas, Helen Parise and Bruce R. Brodie and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

Franz Hartmann

85 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bivalirudin during Primary PCI in Acute Myocardial Infarction

2008 1.2k citations Gregg W. Stone, Bernhard Witzenbichler et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Franz Hartmann Germany	25	3.2k	1.6k	907	713	388	93	4.1k
John Ducas Canada	23	1.8k 0.6×	1.2k 0.7×	653 0.7×	402 0.6×	572 1.5×	99	2.9k
Patricia C. Come United States	36	4.3k 1.4×	1.3k 0.8×	1.1k 1.2×	1.2k 1.7×	967 2.5×	96	5.3k
Peter Ammann Switzerland	30	2.3k 0.7×	734 0.5×	447 0.5×	164 0.2×	522 1.3×	127	3.3k
Markus Haumer Austria	30	807 0.3×	1.2k 0.7×	140 0.2×	379 0.5×	1.4k 3.7×	85	2.8k
Volkhard Kurowski Germany	24	1.6k 0.5×	903 0.6×	783 0.9×	292 0.4×	396 1.0×	60	2.6k
Douglas C. Morris United States	31	3.1k 1.0×	2.5k 1.6×	1.1k 1.3×	195 0.3×	449 1.2×	69	3.9k
Peter Nicol Sweden	12	1.5k 0.5×	586 0.4×	117 0.1×	1.4k 1.9×	134 0.3×	17	2.7k
Arne Høiseth Norway	30	511 0.2×	1.2k 0.8×	174 0.2×	328 0.5×	295 0.8×	91	3.1k
Mahmut Akpek Türkiye	28	1.5k 0.5×	422 0.3×	299 0.3×	339 0.5×	335 0.9×	87	2.5k
In Whan Seong South Korea	33	2.9k 0.9×	2.1k 1.3×	1.3k 1.4×	169 0.2×	455 1.2×	181	3.8k

Countries citing papers authored by Franz Hartmann

Since Specialization

Citations

This map shows the geographic impact of Franz Hartmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franz Hartmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franz Hartmann more than expected).

Fields of papers citing papers by Franz Hartmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Franz Hartmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franz Hartmann. The network helps show where Franz Hartmann may publish in the future.

Co-authorship network of co-authors of Franz Hartmann

This figure shows the co-authorship network connecting the top 25 collaborators of Franz Hartmann. A scholar is included among the top collaborators of Franz Hartmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Franz Hartmann. Franz Hartmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hartmann, Franz, et al.. (2021). Successful interdisciplinary treatment of a rare cause of acute myocardial ischaemia from intermittent tumour-associated obstruction of the left main coronary artery: a case report. European Heart Journal - Case Reports. 5(8). ytab292–ytab292.

Schulze, H, et al.. (2018). A prospective cohort study to assess the relevance of vedolizumab drug level monitoring in IBD patients. Scandinavian Journal of Gastroenterology. 53(6). 670–676. 28 indexed citations

Rakowski, Tomasz, Dariusz Dudek, Artur Dziewierz, et al.. (2013). Impact of infarct-related artery patency before primary PCI on outcome in patients with ST-segment elevation myocardial infarction: the HORIZONS-AMI trial. EuroIntervention. 8(11). 1307–1314. 38 indexed citations

Sinning, Jan‐Malte, Dietrich Baumgart, Nikos Werner, et al.. (2012). Five-year results of the Multicenter Randomized Controlled Open-Label Study of the CYPHER Sirolimus-Eluting Stent in the Treatment of Diabetic Patients with De Novo Native Coronary Artery Lesions (SCORPIUS) study: A German multicenter investigation on the effectiveness of sirolimus-eluting stents in diabetic patients. American Heart Journal. 163(3). 446–453.e1. 16 indexed citations

Mehran, Roxana, Eugenia Nikolsky, Bernhard Witzenbichler, et al.. (2010). COMPLIANCE WITH DUAL ANTIPLATELET THERAPY AND SUBSEQUENT ADVERSE EVENTS IN PATIENTS WITH STEMI UNDERGOING STENT IMPLANTATION: ANALYSIS FROM THE HORIZONS-AMI TRIAL. Journal of the American College of Cardiology. 55(10). A185.E1728–A185.E1728. 2 indexed citations

Caixeta, Adriano, Alexandra J. Lansky, Roxana Mehran, et al.. (2010). Abstract 20882: Predictors of Suboptimal TIMI Flow after Primary Angioplasty for Acute Myocardial Infarction: Results from the HORIZONS-AMI Trial. Circulation. 122. 2 indexed citations

Witzenbichler, Bernhard, Jochen Wöehrle, Giulio Guagliumi, et al.. (2010). IMPACT OF PACLITAXEL-ELUTING STENTS IN DIABETIC PATIENTS WITH ACUTE MYOCARDIAL INFARCTION UNDERGOING PRIMARY ANGIOPLASTY: ANALYSIS FROM THE HORIZONS AMI TRIAL. Journal of the American College of Cardiology. 55(10). A182.E1708–A182.E1708.

Stein, Jürgen M., Franz Hartmann, Hans-Jörg Cordes, & Axel Dignaß. (2009). Pathophysiologisch-orientierte Diagnostik und Therapie der Eisenmangelanämie bei chronisch entzündlichen Darmerkrankungen. Zeitschrift für Gastroenterologie. 47(2). 228–236. 3 indexed citations

Baumgart, Dietrich, Volker Klauß, Frank M. Baer, et al.. (2007). One-Year Results of the SCORPIUS Study. Journal of the American College of Cardiology. 50(17). 1627–1634. 63 indexed citations

10.

Kurowski, Volkhard, Axel Kaiser, Katharina von Hof, et al.. (2007). Apical and Midventricular Transient Left Ventricular Dysfunction Syndrome (Tako-Tsubo Cardiomyopathy) Frequency, Mechanisms, and Prognosis. CHEST Journal. 132(3). 809–816. 412 indexed citations

11.

Tölg, Ralph, Bianca Schwarz, Thomas Kurz, et al.. (2006). Comparison of carvedilol and metoprolol in patients with acute myocardial infarction undergoing primary coronary intervention. Clinical Research in Cardiology. 95(1). 31–41. 21 indexed citations

12.

Lefèvre, Thierry, John A. Ormiston, Giulio Guagliumi, et al.. (2005). The FRONTIER Stent Registry. Journal of the American College of Cardiology. 46(4). 592–598. 57 indexed citations

13.

Hartmann, Franz, Milton Packer, Andrew J.S. Coats, et al.. (2004). NT-proBNP in Severe Chronic Heart Failure: Rationale, Design and Preliminary Results of the COPERNICUS NT-proBNP Substudy. European Journal of Heart Failure. 6(3). 343–350. 74 indexed citations

14.

Hartmann, Franz, et al.. (2003). Influence of creatinine on plasma concentrations and the prognostic value of N-terminal pro-BNP in severe chronic heart failure: Data from a substudy of the COPERNICUS trial. Journal of the American College of Cardiology. 41(6). 143–143. 1 indexed citations

15.

Bonnemeier, Hendrik, Uwe Wiegand, Evangelos Giannitsis, et al.. (2003). Temporal repolarization inhomogeneity and reperfusion arrhythmias in patients undergoing successful primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction: Impact of admission troponin T. American Heart Journal. 145(3). 484–492. 26 indexed citations

16.

Hartmann, Franz, Markus Schwarz, Hendrik Bonnemeier, et al.. (2003). Plasma catecholamines and N-terminal proBNP in patients with acute myocardial infarction undergoing primary angioplasty. Zeitschrift für Kardiologie. 92(1). 73–81. 6 indexed citations

17.

Forstpointner, Roswitha, Roland Repp, Sandra Hermann, et al.. (2002). Rituximab zur Remissionsinduktion bei rezidivierten und refraktaeren indolenten Lymphomen und Mantelzell-Lymphomen: Ergebnisse einer prospektiv randomisierten Studie der deutschen Studiengruppe fuer niedrig maligne Lymphome (GLSG). DMW - Deutsche Medizinische Wochenschrift. 127(43). 2253–2258. 1 indexed citations

18.

Jain, Dilip, Claus Bartels, Matthias Bechtel, et al.. (2001). Early Post-Operative Haemodynamic and Neurohumoral Follow-Up After Endoaneurysmorrhaphy. Journal of clinical and basic cardiology. 4(2). 165–167. 1 indexed citations

19.

Hartmann, Franz, et al.. (1999). Risk Stratification and Therapeutic Decision Making in Patients with Acute Coronary Syndromes the Role of Cardiac Troponin T. Clinical Chemistry and Laboratory Medicine (CCLM). 37(11-12). 1107–1111. 7 indexed citations

20.

Hartmann, Franz, et al.. (1991). Serratia infections in patients with neutropenia. Journal of Molecular Medicine. 69(11). 491–494. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact